London: A COVID-19 antiviral that can be taken at home was approved for use across the UK on Thursday.
With this, Britain has become the first country to give the go-ahead to Molnupiravir, jointly developed by Ridgeback Biotherapeutics and Merck, which is being considered a potential gamechanger in fighting the pandemic, especially in the case of the frailest and immunosuppressed, the BBC reported.
The UK’s Medicines and Healthcare products Regulatory Agency said the tablet has been authorised for use in people who have mild to moderate COVID and at least one risk factor for developing severe illness such as obesity, old age, diabetes or heart disease.
The pill works by interfering with the virus’ replication. This prevents it from multiplying, keeping virus levels low in the body, and thus, reduce the severity of the disease, it said.
The drug needs to be given within five days of symptoms developing to be most effective.
Britain has agreed to purchase 480,000 courses with the first deliveries expected by mid-November.
Molnupiravir will soon be offered to patients, both vaccinated and unvaccinated, in a national study to help protect those most at risk from the virus over the winter, it added.
Bhubaneswar: The 178th State Level Bankers’ Committee (SLBC) meeting was held under the co-chairmanship of… Read More
New Delhi: Youtubers Ranveer Allahbadia and Apoorva Mukhija appeared before the National Commission For Women… Read More
New Delhi: A careless and thoughtless act cost a railway employee dear. A video of… Read More
Bhubaneswar: The Odisha government has launched an International Student Facilitation Cell to assist the students… Read More
New York: Actor Robert Pattinson, who was once a horror buff, is now too scared… Read More
Bhubaneswar: The Kalinga Stadium here will once again stage the Super Cup, featuring the country’s… Read More
This website uses cookies.
